Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
abbvie
drugs
new york
pfizer
san diego blog main
san diego top stories
4d molecular therapeutics
acne
acorda therapeutics
agenus
akcea therapeutics
ampyra
anylam pharmaceuticals
apokyn
apomorphine
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
cardiomyopathy
celgene
What
approved
3
×
disease
3
×
drug
fda
3
×
patients
treatment
acorda
ago
akcea
alnylam
amyloidosis
attr
available
battle
bio
companies
cope
debilitating
digital
epidemic
episodes
fatty
frenzied
friday
genetic
gets
growing
help
known
late
led
liver
looms
meant
medications
medicines
merck
nash
new
news
Language
Current search:
approved
×
disease
×
fda
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms